Xeris Biopharma Inc.

NASDAQ: XERS · Real-Time Price · USD
7.66
0.36 (4.93%)
At close: Aug 15, 2025, 3:59 PM
7.67
0.13%
After-hours: Aug 15, 2025, 07:25 PM EDT

Xeris Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-9.07 -5.2 -1.91 -1.89
PEG Ratio
0.51 0.15 0.03 0.04
PS Ratio
2.45 1.97 1.64 4.67
PB Ratio
-16.8 -47.71 3.99 5.12
P/FCF Ratio
-13.15 -6.56 -1.74 -2.24
P/OCF Ratio
-13.45 -6.88 -1.75 -2.25
OCF/S Ratio
-0.18 -0.29 -0.93 -2.07
Debt / Equity Ratio
-9.17 -33.79 4.38 4.38
Quick Ratio
1.19 1.23 2.20 2.20
Current Ratio
1.67 1.64 2.54 2.54
Asset Turnover
0.63 0.51 0.32 0.14
Interest Coverage
-1.01 -1.65 -5.81 -16.04
Return on Equity
1.85 9.18 -2.09 -2.72
Return on Assets
-0.17 -0.19 -0.27 -0.36
Return on Invested Capital
-0.13 -0.19 -0.29 -0.43
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.82 0.83 0.79 0.73
Net Profit Margin
-0.27 -0.38 -0.86 -2.47
Pretax Profit Margin
-0.28 -0.39 -0.87 -2.47
Operating Profit Margin
-0.17 -0.27 -0.74 -2.32
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.07 -0.14 -0.63 -2.29